Where does AmCad BioMed Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AmCad BioMed Corporation ranks #25,719 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AmCad BioMed Corporation hold?

AmCad BioMed Corporation holds 10 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is AmCad BioMed Corporation's Innovation Score?

AmCad BioMed Corporation has an Innovation Score of 28.2 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does AmCad BioMed Corporation focus on?

AmCad BioMed Corporation's top technology area is G06T (Image Data Processing OR Generation, IN General) with 6 patents, ranking #1,896 of 6,389 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is AmCad BioMed Corporation's patent grant rate increasing or decreasing?

AmCad BioMed Corporation's recent grant velocity is -71% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for AmCad BioMed Corporation's patents?

AmCad BioMed Corporation's patents average 12.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AmCad BioMed Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

AmCad BioMed Corporation

USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G06T (Image Data Processing OR Generation, IN General).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Amcad ranks #25,719 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 9 technology areas.

#25,719
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.2/100): 12.7
avg claims per patent: -71%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25719 · Foreign Corporation #25,719 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #25,719/49,997
PHOTO-FINISH Allsteel
CPC-NARROW G06T · 9 areas
INNOV-THIN 28.2/100
CLAIMS-RICH 12.7 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -71% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Allsteel Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Amcad’s 28.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (29%) Velocity 1.7 pts (6%) Breadth 10.6 pts (38%) Claim depth 7.6 pts (27%)

Qualcomm Incorporated · highest

85
AmCad BioMed · this assignee

28
3D Lighting… · lowest

7

What this shows Amcad's Innovation Score is 28.2/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Amcad?

Each dot is one of Amcad’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Amcad’s own 12.7 claims/patent is at or below the 14.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Amcad vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Amcad's grants concentrate

AmCad BioMed Corporation is a focused PatentsView assignee: 9 CPC subclasses with 60% of grants classified under G06T (Image Data Processing OR Generation, IN General). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2015. By volume, Amcad sits between Allsteel Inc. and America as represented by the Secretary of the Army.

Amcad's three-year grant acceleration

AmCad BioMed Corporation shows 1 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Allsteel

10
Alpha Comm Enterp…

10
Alphora Research

10
Aluminum Industri…

10
Amber Semiconduct…

10
Ambient AI

10
Amchaelvisual Tec…

10
America as repres…

10
Amcad Biomed ◀

10

What this shows AmCad holds 10 patents at rank #25,775, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AmCad

By rank, the assignees closest to #25,775 in granted patent volume.

Leaders in G06T (Image Data Processing OR Generation)

Other assignees with the most granted patents in AmCad's primary technology class.

Amcad's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

AmCad BioMed Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	10.0%
2016	1	10.0%
2017	1	10.0%
2018	1	10.0%
2019	3	30.0%
2020	1	10.0%
2023	1	10.0%
2025partial year	1	10.0%

Which technologies does AmCad BioMed Corporation patent most?

G06T - Image Data Processing OR Generation, IN General 6

A61B - DIAGNOSIS; SURGERY; Identification 6

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G06F - Electric Digital Data Processing 1

G06V - Image OR Video Recognition OR Understanding 1

G02B - Optical Elements, Systems OR Apparatus 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

G06N - Computing Arrangements Based ON Specific Computational Models 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AmCad BioMed Corporation's patent record in context - here's where to go next.

AmCad BioMed Corporation's lead technology class is G06T (Image Data Processing OR Generation, IN General), 60% of its portfolio - see every assignee active in that class. Explore G06T
Ranked #25,719 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AmCad BioMed Corporation against Allsteel Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.